{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:00:23Z","timestamp":1781154023867,"version":"3.54.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary mucormycosis is a life-threatening invasive fungal infection with challenging, often delayed diagnosis and high mortality. This study aims to elucidate the clinical characteristics, diagnostic and therapeutic approaches, and outcomes of pulmonary mucormycosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study enrolled inpatients diagnosed with pulmonary mucormycosis from January 2015 to May 2025. Clinical data were systematically collected and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 16 patients with pulmonary mucormycosis were included in the study. The mean age of the cohort was 52.50\u202f\u00b1\u202f15.02\u202fyears, with a male predominance of 68.75%. Diabetes mellitus was identified as the most prevalent underlying condition, affecting 81.25% of patients. The most common clinical symptoms included cough (100%), expectoration (81.25%), fever (68.75%), chest tightness (68.75%), hemoptysis (50%), and chest pain (50%). Common imaging findings comprised nodules &amp;lt;3\u202fcm (87.50%), consolidation (87.50%), ground-glass opacities (75.00%), halo sign (62.50%), and pleural effusion (50.00%). Of the 16 patients, 68.75% exhibited bronchial involvement. Twelve patients were confirmed by histopathology, and one by culture of sterile pleural fluid; the remaining three were classified as probable cases based on clinical and radiological findings, combined with detection of mucorales by mNGS or from non-sterile specimen cultures. The most frequently identified pathogen was Rhizopus microsporus. Systemic antifungal therapy was administered to 13 patients (81.25%), primarily involving a combination of amphotericin B formulations and azoles. Seventy-five percent of patients underwent bronchoscopic debridement or surgical intervention. The 12-month survival rate was 81.25%, with three patients succumbing to sepsis, massive hemoptysis, or respiratory failure, two of whom had extrapulmonary involvement. In this series, favorable outcomes were observed in patients who received combination therapy, particularly bronchoscopic debridement coupled with antifungal medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pulmonary mucormycosis is highly lethal, frequently associated with bronchial involvement. Bronchoscopy plays a crucial role in both diagnosis and treatment. Combined surgical\/bronchoscopic intervention with systemic and local antifungal therapy may contribute to favorable outcomes in this series.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1844463","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:39:31Z","timestamp":1781152771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features, management, and outcomes of pulmonary mucormycosis: a decade-long retrospective study from a single center in central China"],"prefix":"10.3389","volume":"13","author":[{"given":"Chengqing","family":"Yang","sequence":"first","affiliation":[{"name":"Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Hubei Branch (Wuhan Pulmonary Hospital) of the National Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Mei","sequence":"additional","affiliation":[{"name":"Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Hubei Branch (Wuhan Pulmonary Hospital) of the National Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanze","family":"Cao","sequence":"additional","affiliation":[{"name":"Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Hubei Branch (Wuhan Pulmonary Hospital) of the National Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Mei","sequence":"additional","affiliation":[{"name":"Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Hubei Branch (Wuhan Pulmonary Hospital) of the National Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Chen","sequence":"additional","affiliation":[{"name":"Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Hubei Branch (Wuhan Pulmonary Hospital) of the National Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Liu","sequence":"additional","affiliation":[{"name":"Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Hubei Branch (Wuhan Pulmonary Hospital) of the National Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Quan","sequence":"additional","affiliation":[{"name":"Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Hubei Branch (Wuhan Pulmonary Hospital) of the National Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Hubei Branch (Wuhan Pulmonary Hospital) of the National Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and Meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/tid.12452","article-title":"Disseminated mucormycosis with myocardial involvement in a renal transplant recipient","volume":"17","author":"Nam","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jinf.2023.05.005","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: a national, prospective, and multicentre study","volume":"87","author":"Puerta-Alcalde","year":"2023","journal-title":"J Infect"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s00134-019-05625-x","article-title":"Disseminated mucormycosis","volume":"45","author":"de Roquetaillade","year":"2019","journal-title":"Intensive Care Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.chest.2023.06.039","article-title":"Improving diagnosis of pulmonary mucormycosis: leads from a contemporary National Study of 114 cases","volume":"164","author":"Coste","year":"2023","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.cmi.2020.12.035","article-title":"Has the mortality from pulmonary mucormycosis changed over time? A systematic review and Meta-analysis","volume":"27","author":"Muthu","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"20499361241251744","DOI":"10.1177\/20499361241251744","article-title":"Clinical characteristics, outcome, and factors associated with mortality of pulmonary mucormycosis: a retrospective single-Center study from Pakistan","volume":"11","author":"Khalid","year":"2024","journal-title":"Ther Adv Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4103\/0970-2113.135798","article-title":"Mucormycosis masquerading as an endobronchial tumor","volume":"31","author":"Mahajan","year":"2014","journal-title":"Lung India"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/jof9030307","article-title":"What is new in pulmonary mucormycosis?","volume":"9","author":"Danion","year":"2023","journal-title":"J Fungi"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3760\/cma.j.cn112138-20220729-00557","article-title":"Chinese Mucormycosis Expert Consensus Group. Expert consensus on diagnosis and management of mucormycosis in China","volume":"62","year":"2023","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1103626","DOI":"10.3389\/fcimb.2023.1103626","article-title":"The application of metagenomic next-generation sequencing in patients with infection or colonization caused by Lichtheimia species","volume":"13","author":"Chen","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/1753-0407.12913","article-title":"Diabetes in developing countries","volume":"11","author":"Misra","year":"2019","journal-title":"J Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (Ecmm) working group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/s0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","author":"Zhou","year":"2024","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.21037\/jtd.2019.12.53","article-title":"Clinical features of pulmonary mucormycosis in patients with different immune status","volume":"11","author":"Peng","year":"2019","journal-title":"J Thorac Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1148\/rg.2020190156","article-title":"Pulmonary mucormycosis: risk factors, radiologic findings, and pathologic correlation","volume":"40","author":"Agrawal","year":"2020","journal-title":"Radiographics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1378\/chest.12-0114","article-title":"Reversed halo sign in invasive fungal infections: criteria for differentiation from organizing pneumonia","volume":"142","author":"Marchiori","year":"2012","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2214\/ajr.17.18792","article-title":"Pulmonary mucormycosis: radiologic features at presentation and over time","volume":"210","author":"Hammer","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0832","DOI":"10.1097\/rti.0000000000000832","article-title":"CT features for prognostic assessment of pulmonary mucormycosis in patients with Hematological diseases","volume":"40","author":"Yi","year":"2025","journal-title":"J Thorac Imaging"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00330-017-5007-5","article-title":"Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings","volume":"28","author":"Nam","year":"2018","journal-title":"Eur Radiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/s1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and Management of Mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1580912","DOI":"10.3389\/fmed.2025.1580912","article-title":"Three case reports of pulmonary mucormycosis with a review of the literature","volume":"12","author":"Zhang","year":"2025","journal-title":"Front Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.amjmed.2021.04.008","article-title":"A comparative analysis of mucormycosis in immunosuppressed hosts including patients with uncontrolled diabetes in the Southwest United States","volume":"134","author":"Al-Obaidi","year":"2021","journal-title":"Am J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jinf.2020.05.051","article-title":"Evaluation of Mucorgenius\u00ae Mucorales Pcr assay for the diagnosis of pulmonary mucormycosis","volume":"81","author":"Guegan","year":"2020","journal-title":"J Infect"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.2147\/idr.S454029","article-title":"Clinical manifestation, Mngs based diagnosis and treatment of pulmonary mucormycosis with Rhizopus Delemar in a diabetic patient","volume":"17","author":"Cheng","year":"2024","journal-title":"Infect Drug Resist"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1368165","DOI":"10.3389\/fcimb.2024.1368165","article-title":"Clinical features of Pediatric mucormycosis: role of metagenomic next generation sequencing in diagnosis","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ijid.2022.07.054","article-title":"Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in bronchoalveolar lavage fluid in patients with pulmonary infections: systematic review and Meta-analysis","volume":"122","author":"Chen","year":"2022","journal-title":"Int J Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12941-024-00738-8","article-title":"Clinical characteristics and mortality of mucormycosis in Hematological malignancies: a retrospective study in eastern China","volume":"23","author":"Suo","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-020-1105-z","article-title":"Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids","volume":"27","author":"Gu","year":"2021","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of Zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1844463\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:39:36Z","timestamp":1781152776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1844463\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":32,"alternative-id":["10.3389\/fmed.2026.1844463"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1844463","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"article-number":"1844463"}}